We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,609

Pelman v. McDonald’s Corp.: no class certification for obese teens
  • Shook Hardy & Bacon LLP
  • USA
  • October 29 2010

A judge from the U.S. Court of International Trade, sitting by designation in a New York federal district court, has determined that the obesity-related claims filed in 2002 against McDonald’s Corp. cannot be pursued as a class action


FDA issues final rule on mica-based pearlescent pigments in distilled spirits
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2015

The U.S. Food and Drug Administration (FDA) has issued a final rule allowing "the safe use of mica-based pearlescent pigments prepared from titanium


Food & Beverage Litigation Update: Issue 622
  • Shook Hardy & Bacon LLP
  • USA
  • November 11 2016

Legislation, Regulations and Standards Sonoma County Passes Ban on GMO Crops Voters in Sonoma County, Calif, have passed by a significant margin - 55


FDA refuses to re-classify tooth-whitening products as drugs
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2014

The U.S. Food and Drug Administration (FDA) has denied a Citizen Petition asking the agency to re-categorize tooth-whitening products as drugs


Class certification denied in challenge to efficacy of Natrol supplements
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

A California federal court has denied class certification and dismissed a complaint against Natrol Inc. on subject matter jurisdiction grounds in a


Landmark Texas Supreme Court decision: learned intermediary doctrine applies in prescription drug cases, no DTC exception
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2012

Addressing the issue squarely for the first time, the Texas Supreme Court has unanimously adopted the learned intermediary doctrine in the prescription drug context thereby confirming that manufacturers are only obligated to warn doctors of the risks of prescription medicines


Food & Beverage Litigation Update: Issue 623
  • Shook Hardy & Bacon LLP
  • USA
  • November 18 2016

U.S. Surgeon General Tackles Alcohol Misuse in Addiction Report The U.S. Surgeon General has issued a landmark report intended "to address substance


Guardian Author Takes on Nutritional Establishment in “The Sugar Conspiracy”
  • Shook Hardy & Bacon LLP
  • USA
  • April 8 2016

In this April 7, 2016, article about changing dietary recommendations and rising obesity rates, Ian Leslie resurrects the forgotten work of John


Cosmetic Companies Continue to Receive FDA Warning Letters
  • Shook Hardy & Bacon LLP
  • USA
  • October 7 2016

The U.S. Food and Drug Administration (FDA) sent seven warning letters to cosmetics companies in September 2016, continuing the agency's trend of


FDA Bans 19 Ingredients from Antibacterial Wash Products
  • Shook Hardy & Bacon LLP
  • USA
  • October 7 2016

The U.S. Food and Drug Administration (FDA) has issued a final rule prohibiting the marketing of over-the-counter consumer antiseptic wash products